Camurus AB
Common Name
Camurus
Country
Sweden
Sector
Healthcare
Industry
Biotechnology
Employees
267
Ticker
CAMX
Exchange
NASDAQ STOCKHOLM AB
Website
www.camurus.comDescription
Camurus AB is a research-based pharmaceutical company focused on developing and commercializing innovative and effective medicines. The company's primary focus is on addressing significant unmet medic... Camurus AB is a research-based pharmaceutical company focused on developing and commercializing innovative and effective medicines. The company's primary focus is on addressing significant unmet medical needs within the fields of addiction, pain, cancer, and endocrine disorders. Camurus AB has developed a proprietary drug delivery system known as FluidCrystal® technology, which enables the prolonged release of active substances for improved patient care and compliance.
Headquartered in Lund, Sweden, Camurus AB operates globally, collaborating with various healthcare institutions to enhance the reach and impact of its pharmaceutical products. The company takes products from concept through to commercial reality, demonstrating impressive clinical prowess across its operations. Its strategic partnerships and collaborative initiatives allow for the efficient distribution of its therapeutics across diverse healthcare markets. The firm's innovative approach emphasizes patient convenience, product stability, and therapeutic efficiency. Given its specialized focus, Camurus AB plays a significant role in the pharmaceutical industry by contributing valuable advancements in drug delivery systems and treatment possibilities, ultimately impacting patient care on a global scale.
Camurus's Waste Data Preview
In 2023, Camurus conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards. The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.
| Metric (tonnes) | 2023 | 2022 | 2021 | 2020 - 2017 |
|---|---|---|---|---|
Total Waste Generated | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Waste Recovered | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Hazardous Waste Generated | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | 0000000 |
Non-Hazardous Waste Disposed | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Download Data
Verified Sources Behind Camurus’s Waste Management Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Camurus’s data sources below and access millions more through our Disclosure Search.
a. Camurus's Annual Report 2023
a. Camurus's Annual Report 2023
Want Full Access to Camurus's Waste Management Dataset?
Explore Peer Companies
InnoCare Pharma Ltd
Healthcare
Biotechnology
China (Mainland)
Innovent Biologics Inc
Healthcare
Biotechnology
China (Mainland)
Frontage Holdings Corp
Healthcare
Biotechnology
United States
Ionis Pharmaceuticals Inc
Healthcare
Biotechnology
United States
Alphamab Oncology
Healthcare
Biotechnology
China (Mainland)
WuXi Biologics (Cayman) Inc
Healthcare
Biotechnology
China (Mainland)